(1R,2S,8S,9S)-8-benzyl-11-(2-methyl-[1,3]oxazolo[5,4-d]pyrimidin-7-yl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one

C24H27N5O2 — CID 164688905

IUPAC(1R,2S,8S,9S)-8-benzyl-11-(2-methyl-[1,3]oxazolo[5,4-d]pyrimidin-7-yl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one
SMILESCc1nc2c(N3C[C@H]4C[C@@H](C3)[C@H](Cc3ccccc3)N3C(=O)CCC[C@@H]43)ncnc2o1
InChIInChI=1S/C24H27N5O2/c1-15-27-22-23(25-14-26-24(22)31-15)28-12-17-11-18(13-28)20(10-16-6-3-2-4-7-16)29-19(17)8-5-9-21(29)30/h2-4,6-7,14,17-20H,5,8-13H2,1H3/t17-,18+,19+,20+/m1/s1
InChIKeyPPLPQVAWFLOWJB-FYQPLNBISA-N
MW417.51 g/mol
LogP3.37
Rot. Bonds3

About (1R,2S,8S,9S)-8-benzyl-11-(2-methyl-[1,3]oxazolo[5,4-d]pyrimidin-7-yl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one

(1R,2S,8S,9S)-8-benzyl-11-(2-methyl-[1,3]oxazolo[5,4-d]pyrimidin-7-yl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one (PubChem CID 164688905) has the molecular formula C24H27N5O2 and a molecular weight of 417.51 g/mol. Its IUPAC name is (1R,2S,8S,9S)-8-benzyl-11-(2-methyl-[1,3]oxazolo[5,4-d]pyrimidin-7-yl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one.

Molecular Properties

Compound Name(1R,2S,8S,9S)-8-benzyl-11-(2-methyl-[1,3]oxazolo[5,4-d]pyrimidin-7-yl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one
PubChem CID164688905
Molecular FormulaC24H27N5O2
Molecular Weight417.51 g/mol
Exact Mass417.22
IUPAC Name(1R,2S,8S,9S)-8-benzyl-11-(2-methyl-[1,3]oxazolo[5,4-d]pyrimidin-7-yl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one
SMILESCc1nc2c(N3C[C@H]4C[C@@H](C3)[C@H](Cc3ccccc3)N3C(=O)CCC[C@@H]43)ncnc2o1
InChIInChI=1S/C24H27N5O2/c1-15-27-22-23(25-14-26-24(22)31-15)28-12-17-11-18(13-28)20(10-16-6-3-2-4-7-16)29-19(17)8-5-9-21(29)30/h2-4,6-7,14,17-20H,5,8-13H2,1H3/t17-,18+,19+,20+/m1/s1
InChIKeyPPLPQVAWFLOWJB-FYQPLNBISA-N
XLogP3.37
TPSA75.36 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds3
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500417.51
LogP ≤ 53.37
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Analyze (1R,2S,8S,9S)-8-benzyl-11-(2-methyl-[1,3]oxazolo[5,4-d]pyrimidin-7-yl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (1R,2S,8S,9S)-8-benzyl-11-(2-methyl-[1,3]oxazolo[5,4-d]pyrimidin-7-yl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one?
The IUPAC name of (1R,2S,8S,9S)-8-benzyl-11-(2-methyl-[1,3]oxazolo[5,4-d]pyrimidin-7-yl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one (CID 164688905) is (1R,2S,8S,9S)-8-benzyl-11-(2-methyl-[1,3]oxazolo[5,4-d]pyrimidin-7-yl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one.
What is the SMILES notation for (1R,2S,8S,9S)-8-benzyl-11-(2-methyl-[1,3]oxazolo[5,4-d]pyrimidin-7-yl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one?
The canonical SMILES for (1R,2S,8S,9S)-8-benzyl-11-(2-methyl-[1,3]oxazolo[5,4-d]pyrimidin-7-yl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one is Cc1nc2c(N3C[C@H]4C[C@@H](C3)[C@H](Cc3ccccc3)N3C(=O)CCC[C@@H]43)ncnc2o1.
What is the InChIKey of (1R,2S,8S,9S)-8-benzyl-11-(2-methyl-[1,3]oxazolo[5,4-d]pyrimidin-7-yl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one?
The InChIKey is PPLPQVAWFLOWJB-FYQPLNBISA-N. The full InChI is InChI=1S/C24H27N5O2/c1-15-27-22-23(25-14-26-24(22)31-15)28-12-17-11-18(13-28)20(10-16-6-3-2-4-7-16)29-19(17)8-5-9-21(29)30/h2-4,6-7,14,17-20H,5,8-13H2,1H3/t17-,18+,19+,20+/m1/s1.
What are the key properties of (1R,2S,8S,9S)-8-benzyl-11-(2-methyl-[1,3]oxazolo[5,4-d]pyrimidin-7-yl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one?
(1R,2S,8S,9S)-8-benzyl-11-(2-methyl-[1,3]oxazolo[5,4-d]pyrimidin-7-yl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one has a molecular weight of 417.51 g/mol, XLogP of 3.37, 3 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,2S,8S,9S)-8-benzyl-11-(2-methyl-[1,3]oxazolo[5,4-d]pyrimidin-7-yl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-6-one is sourced from PubChem (CID 164688905), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).